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Effectiveness of Home-Based Pencil Push-ups (HBPP) for 
Patients with Symptomatic Convergence Insufficiency
Kyung Min Kim, Bo Young Chun
Department of Ophthalmology, Kyungpook National University School of Medicine, Daegu, Korea
Purpose: To report the effectiveness of home-based pencil push-ups (HBPP) therapy for patients with symptomatic 
convergence insufficiency.
Methods: Data was collected prospectively on 16 patients who were diagnosed with convergence insufficiency be-
ginning in January 2009. The study group was composed of ten male and six female patients. The duration of 
symptoms, refractive error, distant and near deviation angles, and near point of convergence (NPC) prior to and 
after 12 weeks of HBPP therapy were measured in all patients.
Results: The mean age of the patients was 19.3 years. The mean deviation angle of exophoria was 3 prism diopters 
(PD) at distant and 11.2 PD at near. The mean value of NPC prior to HBPP therapy was 36.3 cm; however, the 
near point of accommodation was within the normal range. After 12 weeks of HBPP therapy, the mean deviation 
angle of exophoria decreased to orthophoric at distant and 4 PD at near. The mean value of NPC decreased to 
14.4 cm. 
Conclusions: Twelve weeks of HBPP therapy appears to be an easy, cost-free and effective therapy for patients 
with symptomatic convergence insufficiency.
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Convergence insufficiency is one of the most common 
causes of ocular discomfort and the most common cause of 
muscular asthenopia [1]. Symptoms of convergence in-
sufficiency include eyestrain, headaches, blurred vision, dip-
lopia, difficulty concentrating, movement of print while 
reading, and lack of comprehension after reading or perform-
ing close-up activities [2-4].
The various treatments of convergence insufficiency can 
be mainly grouped into two categories. Passive treatment, which 
helps to eliminate symptoms, includes base-in prism reading 
glasses. Active treatments, which improve both the symp-
toms and clinical signs, include home-based pencil push-ups 
(HBPP) therapy, office-based vision therapy using orthoptic 
training and surgery such as bilateral medial rectus resection 
[1,4,5]. Recent studies have suggested that HBPP therapy is 
the most commonly prescribed treatment by both oph-
thalmologists and optometrists for symptomatic convergence 
insufficiency in the United States [6,7]. The current study at-
tempts to evaluate the effectiveness of HBPP therapy for 
Korean patients with symptomatic convergence insufficiency.
Materials and Methods
Data was collected prospectively on 30 patients diagnosed 
with convergence insufficiency in January 2009. All patients 
included in the study had exodeviation at least 4 prism diop-
ters (PD) greater at near than at far, a remote near point of 
convergence (NPC) more than 6 cm, insufficient positive fu-
sional vergence (PFV) less than 15 PD base-out break at near 
and normal range near point of accommodation (NPA). 
Patients with abnormal NPA, amblyopia (≥2 line differ-
ence in best-corrected visual acuity between the two eyes), 
anisometropia (≥2 diopters [D] spherical equivalent differ-
ence between the two eyes), history of previous head trauma, 
previously treated with prism glasses, history of strabismus 
surgery, presence of ocular abnormalities, systemic diseases 
or medications known to affect accommodation or vergence Korean J Ophthalmol Vol.25, No.3, 2011
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Table 1. Summary of clinical data 
No. of patients 16
Gender (male:female) 10:6
Age at diagnosis (yr) 19.3 ± 9.9
Refractive error (spherical equivalent)
   OD (diopters) -1.6 ± 1.8
   OS (diopters) -1.4 ± 1.9
Duration of symptoms (mon) 11.6 ± 2.3
Values are presented as mean ± SD. 
Fig. 1. After 12 weeks of home-based pencil push-ups (HBPP) ther-
apy, the mean angle of exodeviation decreased from 3 prism diop-
ters (PD) to orthophoria at distance and from 12 PD to 4 PD at near.
Fig. 2. The mean value of near point of convergence (NPC) de-
creased from 36.6 cm to 14.4 cm after 12 weeks of home-based pen-
cil push-ups (HBPP) therapy.
were excluded. Overall, 16 patients met the criteria for in-
clusion in the present study. The authors followed the tenets 
of the Declaration of Helsinki throughout the study.
Data collected from the medical records included patient 
age, gender, visual acuity, refractive errors, angles of devia-
tion at distance and near, duration of symptoms, NPC, NPA 
and PFV prior to and after 12 weeks of HBPP therapy.
The patients were instructed on the use of HBPP therapy pri-
or to starting treatment, and patients or their parent(s) were 
required to demonstrate how to correctly perform HBPP 
therapy before leaving the clinic. Monthly hospital visits 
were scheduled, and the ability to perform and compliance 
with HBPP therapy were checked at each visit.
In the HBPP procedure, the patient is taught to hold a pencil 
at arm’s length positioned approximately midway between 
the eyes. Then, the patient is instructed to look at and attempt 
to maintain a single image of the pencil while it is being 
moved toward the nose. The patient is told to continue mov-
ing the pencil toward the nose until it is no longer possible to 
view the pencil as a single image. At this point, the pencil 
should be positioned at the most close point at which a single 
image is achieved. If the patient is not able to regain a single 
image, the entire procedure must be repeated. The patients 
were taught to perform two sets of 20 push-ups per day for 12 
weeks.
NPC and PFV were used as indicators of outcome. 
Outcomes were divided into three categories as follows. A 
successful outcome was defined as achievement of both nor-
mal NPC (<6 cm) and normal PFV (>15 PD). An improved 
outcome was defined as having at least one of the following; 
a normal NPC, an improvement of greater than 4 cm in NPC, 
a normal PFV or an increase of greater than 10 PD in PFV. 
Patients who did not meet the criteria for successful or im-
proved outcome were considered to be non-responders.
Results  
Table 1 shows descriptive data for the 16 patients in the 
present study. The mean age of the patients was 19 years 
(range, 7 to 34 years). The mean refractive error (spherical 
equivalent) was -1.6 ± 1.8 D in the right eyes and -1.4 ± 1.9 D 
in the left eyes. There was no difference in mean refractive 
error between the two eyes (p > 0.05). The average duration of 
symptomatic convergence insufficiency was 11.6 ± 2.3 months.
Fig. 1 illustrates the change in mean deviation angle of 
exodeviation prior to and after 12 weeks of HBPP therapy. 
The mean deviation angle at distance decreased from 3 PD to 
orthophoria, and the mean deviation angle at near decreased 
from 12 PD to 4 PD after HBPP therapy. The amount of de-
crease in exodeviation was greater at near than at distance. 
Fig. 2 illustrates the change in mean NPC prior to and after 
12 weeks of HBPP therapy. The mean value of NPC de-
creased from 36.6 cm to 14.4 cm, and the mean value of PFV 
increased from 11.3 PD to 19.1 PD after 12 weeks of HBPP 
therapy.
Table 2 demonstrates outcome measures of the patients 
enrolled in the present study. After 12 weeks of HBPP ther-
apy, ten patients (62.5%) were categorized as either success-KM Kim and BY Chun. Treatment of Symptomatic Convergence Insufficiency
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Table 2. Outcome measures after 12 weeks of home-based
pencil push-ups (HBPP) therapy
No. of patients (%)
Successful
* or improved
† 10 (62.5)
Nonresponders
‡  6 (37.5)
*Successful outcome: achievement of both normal near point of 
convergence (NPC) (<6 cm) and normal positive fusional vergence 
(PFV) (>15 PD); 
†Improved outcome: at least one of the followings,
1) a normal NPC, 2) an improvement of greater than 4 cm in NPC, 
3) a normal PFV, 4) an increase of greater than 10 PD in PFV; 
‡Non-responders: patients who did not meet the above criteria.
ful or improved, and six patients (37.5%) were categorized 
as non-responders. No adverse event that included eyes or 
vision was reported during the 12 weeks of HBPP therapy. 
Discussion
HBPP therapy is a simple, cost-free and easily taught pro-
cedure that involves fewer follow-up visits than does office- 
based therapy (four visits during 12 weeks versus 12 visits in 
12 weeks) [4-9]. Therefore, HBPP therapy is the most com-
monly prescribed treatment for symptomatic convergence in-
sufficiency in the United States [6,7]. In addition, HBPP 
therapy is an especially useful treatment for Korean patients 
with convergence insufficiency because there is no official 
system of licensure for orthoptists in Korea. However, no 
published report previously existed on the result of HBPP 
therapy for patients with symptomatic convergence in-
sufficiency in Korea.
Prior to starting the present study, the authors expected to 
observe somewhat different results from those of other stud-
ies due to the differences in ethnicity and notoriously higher 
near-work demands for Korean students.
The effectiveness of the 12-week HBPP therapy in Korean 
patients with symptomatic convergence insufficiency was 
evaluated. The results from the present study indicated that 
62.5% of the patients showed either successful or improved 
outcomes after 12 weeks of HBPP therapy. The effectiveness 
rate observed in the present study was relatively higher than 
the results of the Convergence Insufficiency Treatment Trial 
study group, which reported that only 20% to 43% of the pa-
tients showed successful or improved outcomes after 12 
weeks of HBPP therapy [4,8,10]. According to these pre-
vious reports, HBPP or other home-based therapy was no 
more effective in decreasing signs or symptoms than was pla-
cebo therapy. Placebo response rates for a variety of medical 
conditions have been reported to range from 15% to 58%, 
with an average placebo effectiveness of 35% [11].
 Thus, the 
effectiveness of HBPP therapy in the present study appears to 
be irrelevant to the placebo effect.
The baseline characteristics of the current study are com-
parable to those of previous studies. The mean deviation an-
gle of near exophoria (12 PD vs. 9 to 11 PD), and PFV values 
at near (11.3 PD vs. 11.8 to 13 PD) were similar between the 
patients enrolled in the present study and those in other stud-
ies [4,8-10]. However, differences were found in the mean 
NPC and patient age. The mean NPC in the present study was 
36.6 cm, which was a significantly worse value than 13.5 cm 
to 14 cm observed in other studies [4,8-10]. The mean age 
was 19 years in the present study and the range (7 to 34 years) 
was wider than the 12 to 24 years seen in other studies 
[4,8-10]. Additionally, the patients were all from a single eth-
nic group. The above-mentioned subject characteristics may 
be the cause of the different success rates between the current 
study and other studies.
There were several different characteristics between the 
successful or improved group and the non-responders group 
in the present study. The improved patients were relatively 
young (less than 17 years) and had smaller exophoria (≤12 
PD) at near fixation. However, four of the non-responder pa-
tients were older than 18 years and all six had larger exo-
phoria (>12 PD). These results correspond with those of a 
previous study which reported that convergence in-
sufficiency is able to be more effectively treated in children 
than in adults [9]. Therefore, the patient’s age and extent of 
exophoria at near fixation may be prognostic factors of 
HBPP therapy for convergence insufficiency.
A positive aspect of the present study is that stricter in-
clusion criteria were used compared to those in other studies. 
The patients with abnormal NPA were excluded in order to 
rule out convergence insufficiency associated with accom-
modative insufficiency. This may be a possible explanation 
for the relatively higher success rate observed in the present 
study as these patients do not respond well to any type of or-
thoptic training [1]. The possibility of inclusion of such pa-
tients in other studies cannot be excluded because the NPA 
values of the patients were not mentioned.
However, the present study has important limitations 
mostly due to a small sample size and lack of symptom level 
measurement using the questionnaire. In addition, the pa-
tients were not divided into children and young adult groups 
as they were in other studies. The current study was not de-
signed to demonstrate maximal improvement with HBPP 
therapy, and a treatment duration longer than 12 weeks may 
have resulted in additional changes in signs and symptoms. 
Furthermore, a much larger prospective study will be neces-
sary to acquire the clinical profiles of Korean patients with 
symptomatic convergence insufficiency.
The current study is the first report to evaluate the effec-
tiveness of a 12-week HBPP therapy in Korean patients with 
symptomatic convergence insufficiency. In summary, the 
study demonstrates that HBPP therapy is an easy, cost-free 
and effective therapy for patients with symptomatic con-
vergence insufficiency. 
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